Friday, December 5, 2008

Conventional Breeding vs Genetic Modification (Part 2)

I got an interesting comment on my article posted sometime ago: http://malaysia4biotech.blogspot.com/2008/07/conventional-breeding-vs-genetic.html.

I started responding to the comment and it got too long, that I decided to post it as an article. Here is my response:

We have to first understand that there is nothing such as absolute safety. But what we can safely say is that in spite of many anti GMO claims, GM crops present not new or different risks. National Academies, Royal Societies and Scientific Societies around the globe have reviewed the underlying science and all have come to the same conclusion. The technology is more precise and better defined than conventional plant breeding and it produces fewer and smaller genetic changes. When regulators in the EU or Australia or Japan approve a new GM crop, they do it with the certainty that it is as safe as any other crop. Determined anti GM activists have spread all sorts of fears about the technology but the scientific community believes that when newly developed GM products are approved by regulators the world over, they are the best studied and safest crops we have ever planted.

There is an extensive scientific literature on safety studies and thousands of papers about safety of specific crops. None of these reveal any flaws in the case-by-case assessment process. Those kinds of studies have been independently done and published. When anti GM activists have no answer for the facts the only thing they can do is try to impeach the source in the hope that listeners will believe them without consulting the literature.

There is more research on GM crops being done in the public sector and in developing countries than there is in the private sector. Big companies have given their technology free of charge to projects designed to help the poor and hungry. People who run misinformation campaigns know that it is always a good idea to give the audience a villain to hate. Many of the arguments against biotech companies are simply anti-globalization and anti-capitalist arguments. It would be better if this debate were held on the merits of globalization and capitalism rather than through a back door attack on a surrogate produced by companies—in this case, GM crops. Personally, I find things produced by giant companies very useful. They produced my computer, my car, the food I eat, the clothes I wear, the communication systems I use, and the energy that cools and powers my house. To those all anti-industry individuals out there, I say – please stop using any products produced by the industry...

I agree completely that it depends on who one listens to and who one believes. One should be very careful in choosing who to believe. In this debate there are giant companies trying to sell products but there are also anti-GM activists whose livelihood comes from continual campaigns against this and other technologies. I have chosen to believe the consensus of the scientific literature. In this case there are numerous peer-reviewed papers that document large reductions in chemical use associated with a switch to GM crops (see Brooks and Barfoot, Pray et al. etc). Given the staggering amount of evidence on this topic it is amazing that those who oppose the technology still go on spreading junk science, oblivious to all the scientific evidence.


That is also another fallacy generated by opponents of GM crops. Saying something again and again doesn’t make it true. FAO says there is not only not enough food in the world to feed the world population and that the situation is getting worse by the day. Food reserves have fallen to all time low and food prices are near all time high. In spite of the Millennium Goals, the number of hungry is going up not down.

Risk analysis is a comparative process in which we analyze one product or process against another. When we compare GM crops with conventional crops we conclude they are actually safer. That’s a scientific risk assessment. It does not mean that conventionally bred crops are unsafe—not at all, we eat them every day and know that they are safe. It does mean that GM crops are no more risky and are usually less risky than conventional foods. There are no villains, monsters or heroes here. Just foods that is as safe as others. The point being made is simply that there is more uncertainty with conventional crops than GM crops, more changes in the DNA could have taken place, composition could have changed more dramatically, and there is a greater risk of producing toxicants or allergens by conventional breeding than there is with GM crops. But none of this means conventional crops are any less safe than we know them to be—it is merely a good way of putting GM crops in the proper perspective to compare their safety with that of conventional crops.

By Mahaletchumy Arujanan

Tuesday, December 2, 2008

Opportunities in Biobusiness: Creating Wealth with Biology

Anyone who is looking to invest should seriously consider Asia. This is the fastest growing region that offers great opportunities. With its population rapidly moving up the socioeconomic hierarchy, there are unlimited opportunities for investors and entrepreneurs to create value and wealth. One area that generates lots of excitement is “biology” or “biotechnology” to be more specific.

Biotechnology is an age-old technology that has evolved tremendously to meet the modern requirements of humankind and at same time contributes towards the well-being of the environment. Many successful bioentrepreneurs have proven that the popular notion that scientists can’t make money is merely a myth. What is required is probably a good sense of business orientation, some knowledge in finance, marketing, and other entrepreneur skills. Not to forget perseverance and the right mindset.

Recently I read a book authored by Prof. Paul Teng of Nanyang Technological University Singapore – “Bioscience Entrepreneurship in Asia: Creating Value with Biology”. One will be surprised by the various means offered by biology for the creation of value and wealth. This area is not just limited to highly skilled personnel, scientists or huge multinationals but the doors are open to people from all walks of life and for small entreprises too. One simple example is the production of planting materials using tissue culture techniques. Once the skills and the inner works of tissue culture are mastered, anyone can start a ‘production line’ to produce quality planting materials. There is huge potential and market in this area – from producing for plantation to nurseries and household. The plants too can vary from fruits trees to ornamental, commodities, herbs, and timber.

Biopesticides and biofertilizers, anyone? There are numerous options in these areas as well. Not to mention production of food, organic acids, enzymes, vitamins, and amino acids through biofermentation.

Have you ever imagined a mushroom business? This can lead to the production of food and nutraceuticals.

What I have mentioned here are just a few examples. There are unlimited options. A good approach might be some joint ventures with research institutes and scientists who could offer their expertise for beginners. A number of research institutes in Malaysia such as MARDI and FRIM offer licenses to those interested in using their technology for commercialization. With the incentives and support provided by the government through the Malaysian Biotechnology Corporation, the dream of owning a bioenterprise is within reach.

Furthermore, through this industry, bioentrepreneurs are able to contribute to the wellbeing of the nation and community as products, technology and services developed using biotechnology could help to enhance the quality of life, food security, and reduce negative impact to the environment.

The good news is, in Asia the industry has not reached its saturation point and there are unexploited market, products, technology and services. One just has to be innovative and bark the right tree.

For those who are interested to read the book, look for Bioscience Entrepreneurship in Asia: Creating Value in Biology, Paul S. Teng, 2008. World Scientific.

by Mahaletchumy Arujanan

Friday, November 28, 2008

MABIC is hiring!

MABIC is looking for a suitable candidate to fill in the position of Biotechnology Information Officer. Below are the details:

The Job:

· The Biotechnology Information Officer will be fully responsible for the management of MABIC website, its databases and information resources
· Assist the Executive Director in initiating programmes and activities for its stakeholders
· Take up speaking engagements
· Helps in the dissemination of information about biotechnology to stakeholders and responds to queries
· Coordinate logistics for MABIC activities such as seminars, workshops, and meetings

 

The Person:
· Possess at least a Bachelor’s degree in biotechnology, biology or any related field
· Has excellent command of written and spoken English language
· Basic knowledge of information technology tools, such as HTML, database
· Able to work independently but a team player
· Willing to travel both within and outside Malaysia
· Excellent interpersonal skills
· At least 1-2 years of experience, but fresh graduates are encouraged to apply
 

For more information on MABIC, visit: www.bic.org.my


Applications should be sent to:
Executive Director
Malaysian Biotechnology Information Centre
2-5-40 Monash University Malaysia
Jalan Lagoon Selatan, Bandar Sunway
46150 Petaling Jaya, Selangor
Tel: 03-551 46174
Fax: 03-55146184

Email: info@bic.org.my

Tuesday, November 25, 2008

Internships: First dip into the industry

The completion of a tertiary education can never be said as being fulfilled without industry experience. Students, who have been cooped up in the ivory tower for so long, find it hard to adapt to the dynamic and demanding lifestyle of the working environment without prior experience. Similarly, many companies have been complaining on the lack-luster quality of graduates, unable to cope with the needs and demands of the industry. I have mentioned this previously in many of my posts on nurturing human capital, and I have generally held the view that both parties should be more proactive and held responsible for this predicament. However, I foresee a way out. It is called “an internship”, aka industrial training.



If one looks at most established companies, it is not hard to find interns milling about the company premises. Many a story have been written about the experiences of an intern, ranging from being treated as an office boy/girl, to being shown the loops of the industry which culminated in an ultimately successful career. However it may turn out, this would still be a student’s first experience with the industry. Even if the supervisor is a Miranda Priestly (of Devil Wears Prada persuasion) wannabe, there are far more that one may experience through the “ordeal”. In the words of an acquaintance of mine, “The ‘horror’ (of the bad internship) will end, but the links and connections (forged during this period) will survive.”




Not that I am trying to say that internships would be horrifying, but it certainly is a challenge. And unless students are not only willing to step up to the challenge, but also be proactive in seeking opportunities to improve oneself, they would be left behind.




Companies and policy makers are starting to understand the importance of such training. At a recent seminar, the general manager of a Bionexus status bioinformatics company mentioned to the general audience that the company has an internship programme to help graduates understand the loops of the industry. The Managing Director of a biotech product development company has mentioned to me on many occasions how he employs staff from the various interns the company takes in from the biotech field every year. Similarly, BiotechCorp, the one stop biotech support center under the purview of MOSTI, had announced a Biotechnology Special Training Programme for Unemployed Life Sciences Graduates (BeST) which is a six-month intensive and structured retooling programme combining classroom-based instruction, laboratory work and industry internship.




The opportunities that are available are endless. Now, with the “adults” opening up the avenues and showing the way to move to students, my only advice is, “Go, explore and experience to the fullest”. Maybe one day, the “lowly” intern will blossom and become one of the movers-and-shakers of the local or even global biotech industry.

Monday, November 17, 2008

EU’s GM aversion costs €2.5 billion a year

The European livestock sector is losing €2.5bn a year thanks to EU time-wasting on authorising GM feeds and a zero-tolerance policy on new GM varieties, according to a report by agricultural trade researchers.

While feed prices have been hit by poor harvests and world-wide shortages, EU import bans on GM maize have pushed up prices further, the report by organisations including the Agricultural Industries Confederation says.

An estimated 15% of losses in the sector are caused by EU delays, it adds.

The researchers, who have sent their report to European Commission president Jose Manuel Barrosso, said policy needed to change before the livestock industry was "destroyed" due to lack of feeds.

AIC said the situation would get worse unless EU policy towards GMs was altered.

With new GM varieties due to be commercialised in 2009, increased use of GM crops in North America and Brazil and GM residues contaminating non-GM crops, finding importers who could provide non-GM soya feeds would become increasingly difficult, AIC said.

The EU is 78% dependent on imported animal proteins like soya and there are few domestic alternatives, it added.

by Lucy Busuttil for Farmers Weekly Interactive

Comments from malaysia4biotech:
It is amusing that EU bans GM feed but imports livestock products of animals fed with GM feed. It is clear that the denial of GM products in the EU is nothing more than a trade barrier. This double standard completely lacks science-based decisions. EU is already facing pressure from their farming communities to allow GM feed to enter the country. With the current global shortage of grains, the government will have a big problem persuading consumers that GMOs are safe, when they have denied this in the past.
Many developing countries are influenced by the positions taken by EU, which is heavily influenced by Green NGOs.

Norman Borloug, Father of Green Revolution says this:
"Some of the environmental lobbyists of the Western nations are the salt of the earth, but many of them are elitists. They've never experienced the physical sensation of hunger. They do their lobbying from comfortable office suites in Washington or Brussels. If they lived just one month amid the misery of the developing world, as I have for fifty years, they'd be crying out for tractors and fertilizer and irrigation canals and be outraged that fashionable elitists back home were trying to deny them these things."

When NGOs say we need to farm sustainably, they mean the farmers... not them. These NGOs should try to get themselves dirty in the soilbeds, sweating and back-breaking, with a fork and spade. Imagine being a woman trying to feed five kids, lost her husband to HIV, working from dawn to sunset on arid land, without irrigation, fresh water, fertilisers and quality seeds. Who deprives them of technology and quality life?
By Mahaletchumy Arujanan

Thursday, November 13, 2008

Global Entrepreneurship Week Seminar: Bio-entrepreneurship: Driving the New Economy

Bio-entrepreneurship: Driving the New Economy

19th November 2008
University Kuala Lumpur


The 21 st century has been widely touted as a century for the renaissance of the ‘New Biology' in the form of life science and biotechnology. Asia is currently a source of global economic growth where the demand for bio0based products for food, feed, fiber and industrial materials is fast growing. Putting all these together gives an exciting mix for innovation and entrepreneurship. Malaysia realized these opportunity and has a forward looking biotechnology policy in place which was launched in 2005.

The Malaysian Biotechnology Information Centre (MABIC) and Malaysian Bio Industry Organization (MBIO) are jointly organizing a seminar on “Bioentrepreneurship: Driving the New Economy”. This seminar is hosted by University Kuala Lumpur and is in conjunction with the Global Entrepreneurship Week (GEW) which is a global initiative to inspire young people to embrace innovation and creativity.

The seminar will feature industry players from Synamatix Sdn Bhd (a bioinformatics company with global presence), Infovalley Sdn Bhd (a BioIT company), StemLife Sdn Bhd (the pioneer in stem cell banking and therapy), and a scientists from Forest Research Institute Malaysia who has successfully created many entrepreneurs producing planting materials from tissue culture. Dr. Arif Anwar, Mr. Mathavan Chandran, Ms. Su Hu Yong, and Dr. Kodiswaran Kandasamy will speak on the various opportunities available in biobusiness based on their scope of business, starting up biobusiness, the challenges, potential, the needs of the business, and what it takes to be successful in this area.

Admission is Free.

For more information and registration, please call Mr. Liew Kong Cheng: 016 3681987 or email: cheng@bic.org.my